相关实验视频
Updated: Jun 30, 2026

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.7K
一个案例研究发现了遗传性多变性心肌病的TTN基因中的新突变
Jiangtao Dong1,2,3,4, Meilin Liu1,2,3, Qianwen Chen1,2,3,5
1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
International journal of general medicine
|February 3, 2025
概括
在一个患有多变性心肌病症 (HCM) 的中国家庭中发现了TTN基因的新型突变. 基因检测证实了这种突变是受影响家庭成员中HCM的原因,有助于诊断和风险评估.
科学领域:
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 增高性心肌病变 (HCM) 是一种常见的遗传性心脏病,大约三分之一的患者有未知的遗传原因.
- 萨尔科默蛋白基因的突变解释了40-60%的HCM病例,但需要新的基因发现.
- 整体外因子测序 (WES) 是一种强大的工具,用于识别疾病的遗传原因.
研究的目的:
- 在一个中国家庭中识别高性心肌病 (HCM) 的遗传病因.
- 调查新型基因突变在HCM病原发生中的作用.
- 在受影响的家庭中进行系统的遗传查.
主要方法:
- 整体外体序列测序 (WES) 是对中国HCM血统的家庭成员进行的.
- 用桑格测序验证了候选变体.
- 生物信息分析被用来评估发现突变的致病性.
主要成果:
- 在TTN基因中发现了一种新型异构性误解突变 (c.20233 C>T,p.R6745C).
- 预计这种TTN突变会损害蛋白质功能,并且在受影响的个体中发现,但在健康的成员中没有发现 (除了一个孩子).
- 突变在家族内与HCM分离,表明它在疾病引起中的作用.
结论:
- 在中国的HCM家族中发现了一种新的致病性TTN基因突变.
- 血统查确定了引起疾病的基因载体,支持了突变的作用.
- 这些发现强调了基因检测对HCM诊断,风险分层和早期干预的重要性.
相关概念视频
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

